Cargando…

mRNA COVID-19 Vaccine Related Myocarditis and Pericarditis in the Australian Capital Territory

Detalles Bibliográficos
Autores principales:	O'Driscoll, R., Fang, J., Raman Srinivasan, J., Wilson, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345542/ http://dx.doi.org/10.1016/j.hlc.2022.06.355

Ejemplares similares

COVID-19 mRNA vaccination and myocarditis or pericarditis
por: Husby, Anders, et al.
Publicado: (2022)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

PRAC updates risk of myocarditis and pericarditis with mRNA vaccines
Publicado: (2021)

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination
por: Weintraub, Eric S., et al.
Publicado: (2022)

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
por: Alami, Abdallah, et al.
Publicado: (2022)

Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Publicado: (2022)

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective
por: Alami, Abdallah, et al.
Publicado: (2023)

Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers
por: Luk, Adriana, et al.
Publicado: (2021)

COVID-19-Induced Myocarditis and mRNA Vaccine-Related Pericarditis: A Case Report
por: Voltarelli, Clara L, et al.
Publicado: (2022)

COVID-19 mRNA Vaccine Myocarditis at a Tertiary Australian Hospital
por: McCann, M., et al.
Publicado: (2022)

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis
por: Alami, Abdallah, et al.
Publicado: (2023)

Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre
por: Istampoulouoglou, Ioanna, et al.
Publicado: (2021)

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
por: Das, Bibhuti B., et al.
Publicado: (2021)

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
por: Goddard, Kristin, et al.
Publicado: (2022)

Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis
por: Wassif, Marina, et al.
Publicado: (2023)

A Pharmacoepidemiological Study of Myocarditis and Pericarditis Following the First Dose of mRNA COVID-19 Vaccine in Europe
por: Tome, Joana, et al.
Publicado: (2023)

Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada
por: Buchan, Sarah A., et al.
Publicado: (2022)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
por: Rafaniello, Concetta, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases
por: Wong, Hui-Lee, et al.
Publicado: (2022)

Myocarditis and pericarditis following mRNA vaccination in autoimmune inflammatory rheumatic disease patients: A single‐center experience
por: Patel, Shreeya, et al.
Publicado: (2022)

Comment on: Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis
por: Zafar, Wirda, et al.
Publicado: (2023)

Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines
por: Abraham, Natalia, et al.
Publicado: (2022)

Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination
por: Lane, Samantha, et al.
Publicado: (2022)

Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination
Publicado: (2022)

Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines
por: Naveed, Zaeema, et al.
Publicado: (2022)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 mRNA Vaccine and Myocarditis
por: Singh, Balraj, et al.
Publicado: (2021)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021)

Food Habits of Older Australians Living Alone in the Australian Capital Territory
por: Low, Elizabeth, et al.
Publicado: (2020)

Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study
por: Park, Hwanhee, et al.
Publicado: (2021)

Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system
por: Chen, Congqin, et al.
Publicado: (2022)

Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events
por: Kobayashi, Hidetaka, et al.
Publicado: (2022)

Myocarditis Associated with mRNA COVID-19 Vaccination
por: Starekova, Jitka, et al.
Publicado: (2021)

Myocarditis following COVID-19 mRNA vaccination
por: Parmar, Kanak, et al.
Publicado: (2021)

COVID-19 mRNA Vaccine-Associated Myocarditis
por: Kyaw, Htin, et al.
Publicado: (2022)

Myocarditis following COVID-19 mRNA vaccination
por: Abu Mouch, Saif, et al.
Publicado: (2021)

Myocarditis and pericarditis after vaccination for COVID‐19
por: Hudson, Blake, et al.
Publicado: (2021)

Myocarditis, pericarditis with COVID-19 vaccines in the Netherlands
Publicado: (2021)

Myocarditis or pericarditis following COVID-19 vaccination
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e6igf9ja1n4uou4kotsfjtjeds